Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Adding quantitative muscle MRI to the FSHD clinical trial toolbox.

Mul K, Vincenten SCC, Voermans NC, Lemmers RJLF, van der Vliet PJ, van der Maarel SM, Padberg GW, Horlings CGC, van Engelen BGM.

Neurology. 2017 Nov 14;89(20):2057-2065. doi: 10.1212/WNL.0000000000004647. Epub 2017 Oct 13.

2.

Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.

Janssen BH, Voet NB, Nabuurs CI, Kan HE, de Rooy JW, Geurts AC, Padberg GW, van Engelen BG, Heerschap A.

PLoS One. 2014 Jan 14;9(1):e85416. doi: 10.1371/journal.pone.0085416. eCollection 2014.

3.

Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2.

Mair D, Huegens-Penzel M, Kress W, Roth C, Ferbert A.

Eur Neurol. 2017;77(1-2):32-39. doi: 10.1159/000452763. Epub 2016 Nov 18.

PMID:
27855411
4.

MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.

Andersen G, Dahlqvist JR, Vissing CR, Heje K, Thomsen C, Vissing J.

J Neurol. 2017 Mar;264(3):438-447. doi: 10.1007/s00415-016-8361-3. Epub 2016 Dec 20.

PMID:
28000006
5.

Muscle MRI findings in facioscapulohumeral muscular dystrophy.

Gerevini S, Scarlato M, Maggi L, Cava M, Caliendo G, Pasanisi B, Falini A, Previtali SC, Morandi L.

Eur Radiol. 2016 Mar;26(3):693-705. doi: 10.1007/s00330-015-3890-1. Epub 2015 Jun 27.

PMID:
26115655
6.

Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.

Kan HE, Scheenen TW, Wohlgemuth M, Klomp DW, van Loosbroek-Wagenmans I, Padberg GW, Heerschap A.

Neuromuscul Disord. 2009 May;19(5):357-62. doi: 10.1016/j.nmd.2009.02.009. Epub 2009 Mar 28.

PMID:
19329315
7.

Leg muscle involvement in facioscapulohumeral muscular dystrophy assessed by MRI.

Olsen DB, Gideon P, Jeppesen TD, Vissing J.

J Neurol. 2006 Nov;253(11):1437-41. Epub 2006 Jun 13.

PMID:
16773269
8.

Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers.

Mul K, Horlings CGC, Vincenten SCC, Voermans NC, van Engelen BGM, van Alfen N.

J Neurol. 2018 Nov;265(11):2646-2655. doi: 10.1007/s00415-018-9037-y. Epub 2018 Sep 6.

9.

Clinical Muscle Testing Compared with Whole-Body Magnetic Resonance Imaging in Facio-scapulo-humeral Muscular Dystrophy.

Regula JU, Jestaedt L, Jende F, Bartsch A, Meinck HM, Weber MA.

Clin Neuroradiol. 2016 Dec;26(4):445-455. Epub 2015 Apr 10.

PMID:
25860436
10.

MRI change metrics of facioscapulohumeral muscular dystrophy: Stir and T1.

Ferguson MR, Poliachik SL, Budech CB, Gove NE, Carter GT, Wang LH, Miller DG, Shaw DWW, Friedman SD.

Muscle Nerve. 2018 Jun;57(6):905-912. doi: 10.1002/mus.26038. Epub 2018 Mar 3.

PMID:
29236297
11.

Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.

Janssen BH, Pillen S, Voet NB, Heerschap A, van Engelen BG, van Alfen N.

Muscle Nerve. 2014 Dec;50(6):968-75. doi: 10.1002/mus.24247. Epub 2014 Oct 30.

PMID:
24659533
12.

Quantitative MRI reveals decelerated fatty infiltration in muscles of active FSHD patients.

Janssen B, Voet N, Geurts A, van Engelen B, Heerschap A.

Neurology. 2016 May 3;86(18):1700-7. doi: 10.1212/WNL.0000000000002640. Epub 2016 Apr 1.

PMID:
27037227
13.

Only fat infiltrated muscles in resting lower leg of FSHD patients show disturbed energy metabolism.

Kan HE, Klomp DW, Wohlgemuth M, van Loosbroek-Wagemans I, van Engelen BG, Padberg GW, Heerschap A.

NMR Biomed. 2010 Jul;23(6):563-8. doi: 10.1002/nbm.1494.

PMID:
20175146
14.

Whole-body magnetic resonance imaging evaluation of facioscapulohumeral muscular dystrophy.

Leung DG, Carrino JA, Wagner KR, Jacobs MA.

Muscle Nerve. 2015 Oct;52(4):512-20. doi: 10.1002/mus.24569. Epub 2015 Mar 31.

15.

Muscle Quantitative MR Imaging and Clustering Analysis in Patients with Facioscapulohumeral Muscular Dystrophy Type 1.

Lareau-Trudel E, Le Troter A, Ghattas B, Pouget J, Attarian S, Bendahan D, Salort-Campana E.

PLoS One. 2015 Jul 16;10(7):e0132717. doi: 10.1371/journal.pone.0132717. eCollection 2015.

16.

Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study.

Fatehi F, Salort-Campana E, Le Troter A, Lareau-Trudel E, Bydder M, Fouré A, Guye M, Bendahan D, Attarian S.

PLoS One. 2017 Aug 25;12(8):e0183825. doi: 10.1371/journal.pone.0183825. eCollection 2017.

17.

[Skeletal muscle MRI of lower limbs in patients with facioscapulohumeral dystrophy].

Ma MM, Song J, Zhang JW, Gao L, Pang M, Li G, Fu J.

Zhonghua Yi Xue Za Zhi. 2019 Mar 5;99(9):675-679. doi: 10.3760/cma.j.issn.0376-2491.2019.09.008. Chinese.

PMID:
30831616
18.

Severe paraspinal muscle involvement in facioscapulohumeral muscular dystrophy.

Dahlqvist JR, Vissing CR, Thomsen C, Vissing J.

Neurology. 2014 Sep 23;83(13):1178-83. doi: 10.1212/WNL.0000000000000828. Epub 2014 Aug 20.

PMID:
25142899
19.

Relationship between muscle inflammation and fat replacement assessed by MRI in facioscapulohumeral muscular dystrophy.

Dahlqvist JR, Andersen G, Khawajazada T, Vissing C, Thomsen C, Vissing J.

J Neurol. 2019 May;266(5):1127-1135. doi: 10.1007/s00415-019-09242-y. Epub 2019 Feb 18.

PMID:
30778707
20.

Muscle MRI of facioscapulohumeral dystrophy (FSHD): A growing demand and a promising approach.

Fatehi F, Salort-Campana E, Le Troter A, Bendahan D, Attarian S.

Rev Neurol (Paris). 2016 Oct;172(10):566-571. doi: 10.1016/j.neurol.2016.08.002. Epub 2016 Sep 20. Review.

PMID:
27663058

Supplemental Content

Support Center